Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Lung adenocarcinoma; Surgery; Recurrence factor;
مقالات ISI جهش گیرنده فاکتور رشد اپیدرمال (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non-small cell lung cancer; Brain metastases; Epidermal growth factor receptor mutation; Tyrosine kinase inhibitors; Therapeutic outcomes;
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; SNPs; single-nucleotide polymorphisms; EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; ADC; lung adenocarcinoma; LCINS; lung cancer in never-smokers; ALK; anaplastic lymphoma kinase; GWAS; genome-wide association studies; HKU/HA
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Lung cancer; Early adenocarcinoma; Subtype; Immunohistochemistry; Epidermal growth factor receptor mutation;
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Brain metastasis; Epidermal growth factor receptor mutation; Non-small-cell lung cancer; Pathological stage; Postoperative recurrence survival;
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; BIM deletion polymorphism; Non-small-cell lung cancer; Epidermal growth factor receptor mutation; EGFR tyrosine kinase inhibitor; Chemotherapy;
ReviewOptimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Acquired resistance; Epidermal growth factor receptor mutation; Non-small cell lung cancer; Osimertinib; T790M; Tyrosine kinase inhibitor;
Original researchProgrammed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Programmed death-ligand 1; T790M; Epidermal growth factor receptor mutation; Non-small cell lung cancer; Rebiopsy;
ReviewWhat do we need to make circulating tumour DNA (ctDNA) a routine diagnostic test in lung cancer?
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Circulating tumour DNA; Liquid biopsy;
Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non-Small-Cell Lung Cancer
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Erlotinib; Non-small cell lung cancer; Ramucirumab; RELAY trial;
Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; LM; Non-small-cell lung cancer; Risk factor; TKI;
Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Cost-effectiveness; Epidermal growth factor receptor mutation; Mutation-specific antibodies; NSCLC; Survival;
Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Chemoradiation; Epidermal growth factor receptor mutation; Local neoplasm recurrence; Non-small cell lung cancer; Radiation field;
Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Non-small cell lung cancer; Circulating tumor DNA; Discordance of mutation; Heterogeneity;
Original ArticleTranslational OncologyCT Features of Epidermal Growth Factor Receptor-Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Lung adenocarcinoma; Computed tomography; Lung cancer;
A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Bevacizumab; Non-small-cell lung cancer; Epidermal growth factor receptor mutation; Second-line; Carboplatin; Paclitaxel;
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; T790M; Epidermal growth factor receptor-tyrosine kinase inhibitor; Acquired resistance; Rebiopsy
RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non-small cell lung cancer; Epidermal growth factor receptor mutation; EGFR tyrosine kinase inhibitors;
Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non-small cell lung cancer; Epidermal growth factor receptor mutation; Tyrosine kinase inhibitor; Gefitinib; Chemotherapy; Cisplatin; Docetaxel;
Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non-small cell lung carcinoma; Epidermal growth factor receptor mutation; EGFR tyrosine kinase inhibitor; Primary resistance; Overall survival; BIM polymorphism;
Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non-small cell lung cancer; Epidermal growth factor receptor mutation; Epidermal growth factor receptor tyrosine kinase inhibitor; Nicotine; Cigarette smoking;
Epidermal Growth Factor Receptor Mutations: Effect on Volume Doubling Time of Non-Small-Cell Lung Cancer Patients
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Volume doubling time; Epidermal growth factor receptor mutation; Non-small-cell lung cancer;
EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Pulmonary adenocarcinoma; Brain metastasis; Cranial metastasis;
Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non–small-cell lung cancer; Gefitinib; Erlotinib; Epidermal growth factor receptor mutation
Primary lung adenocarcinoma with morule-like components: A unique histologic hallmark of aggressive behavior and EGFR mutation
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Lung adenocarcinoma; Morule; Epidermal growth factor receptor mutation; Unfavorable outcome; Intracytoplasmic mucin; Micropapillary
Treatment of Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation or ALK Gene Rearrangement: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; ALK rearrangement; Epidermal growth factor receptor mutation; Non–small-cell lung cancer
Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Hepatocyte growth factor; Vascular endothelial growth factor; Epidermal growth factor receptor-tyrosine kinase inhibitor resistance; Lung cancer; Epidermal growth factor receptor mutation;
High Expression of Dihydropyrimidine Dehydrogenase in Lung Adenocarcinoma is Associated With Mutations in Epidermal Growth Factor Receptor: Implications for the Treatment of Non-Small-Cell Lung Cancer Using 5-Fluorouracil
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Adenocarcinoma in situ; Dihydropyrimidine dehydrogenase; epidermal growth factor receptor mutation; epidermal growth factor receptor tyrosine kinase inhibitor; S-1;
Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Non-small cell lung cancer; Gefitinib; Body surface area; Tyrosine kinase inhibitor; Progression free survival
Prospective Assessment of Continuation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Pemetrexed
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non–small-cell lung cancer; Erlotinib; Gefitinib; Pemetrexed; Epidermal growth factor receptor mutation; Acquired resistance.
Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Adenocarcinoma; Epidermal growth factor receptor mutation; High resolution computed tomography; Idiopathic interstitial pneumonia; Interstitial lung disease; Usual interstitial pneumonia
Small-Cell Carcinoma in the Setting of Pulmonary Adenocarcinoma: New Insights in the Era of Molecular Pathology
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Combined small-cell carcinoma; Pulmonary adenocarcinoma; Molecular pathology; Epidermal growth factor receptor mutation; Pathology
Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non–small-cell lung cancer; Epidermal growth factor receptor mutation; Colony hybridization
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Advanced non–small-cell lung cancer; Epidermal growth factor receptor mutation; Epidermal growth factor receptor tyrosine kinase inhibitor
First-Line Gefitinib in Patients Aged 75 or Older With Advanced Non–Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: NEJ 003 Study
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non–small cell lung cancer; Epidermal growth factor receptor mutation; Gefitinib
Detection of EGFR Mutation Status in Lung Adenocarcinoma Specimens with Different Proportions of Tumor Cells Using Two Methods of Differential Sensitivity
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Direct sequencing; Epidermal growth factor receptor mutation; Lung adenocarcinoma; PNA clamping; Sensitivity
Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief Report
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Epidermal growth factor receptor mutation; Gefitinib; Small cell lung cancer
Adenocarcinoma of lung in never smoked children
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Adenocarcinoma of lung; Pulmonary tuberculosis; Smoking; Epidermal growth factor receptor mutation; Children
Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancer
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; Non-small-cell lung cancer; Lung adenocarcinoma; Brain metastasis; Epidermal growth factor receptor mutation; Receptor tyrosine kinase inhibitor; Erlotinib; Gefitinib
Detection of Epidermal Growth Factor Receptor Mutation in Transbronchial Needle Aspirates of Non-Small Cell Lung Cancer
Keywords: جهش گیرنده فاکتور رشد اپیدرمال; epidermal growth factor receptor; epidermal growth factor receptor mutation; epidermal growth factor receptor tyrosine kinase inhibitor; Scorpions Amplified Refractory Mutation System; transbronchial needle aspirationARMS, Amplified Refractory Mutation Sy